Internships build student confidence, benefit businesses
He came to DSU from Ohio for college, fell in love with his future career field — and then landed this incredible internship.
He came to DSU from Ohio for college, fell in love with his future career field — and then landed this incredible internship.
In one place, you’ll now find updates on all Avera research and easy access to clinical trials.
Alucent Biomedical Inc., which was founded by Avera Health to commercialize products using natural vascular scaffolding technology, has closed a $35 million Series B financing round.
After two decades in development, a unique drug and device combination for a hard-to-treat disease will have a new home at the USD Discovery District.
SAB Biotherapeutics and Alumend are the first companies to announce plans to locate at the USD Discovery District.
Three companies with a huge range of promising technologies will be part of a panel discussion June 15 at Breakthrough, an annual summit and banquet for South Dakota Biotech.
A technology to treat peripheral vascular disease that was developed in a Sioux Falls lab and acquired by Avera has been approved for clinical trials.